November 3, 2016

As real-world evidence of product value becomes absolutely paramount to successful market entry and access globally, especially in light of increasing chronic disease management complexities and extraordinary payer budget pressures, our clients are increasingly in need of strategic advisory and tactical services related to real-world evidence generation and communication. This global partnership, stemming from years of the leadership of both groups working together, will offer ApotheCom’s clients an enhanced suite of offerings along the market access pathway, including RWE planning, data analytics, insights generation, economic modelling, and communication tools and platforms. All of this will better help clients effectively tell their value story based on compelling real-world scientific and economic evidence – resulting in better reimbursement placement and positioning and patient access to innovative therapies.